A. Montag and Associates »

Affimed Therapeutics B V shares owned by A. Montag and Associates

Quarter-by-quarter ownership of Affimed Therapeutics B V shares owned by A. Montag and Associates from 13F filings

Historical chart of A. Montag and Associates investment in Affimed Therapeutics B V

Tip: Access up to 7 years of quarterly data

All positions including Affimed Therapeutics B V held by A. Montag and Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Affimed Therapeutics B V by A. Montag and Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3k 10k 0.63

More positions owned by A. Montag and Associates

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Alphabet Cap Stk Cl C (GOOG)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Coca-Cola Company (KO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Rus 1000 Etf (IWB)
Home Depot (HD)
Amazon (AMZN)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core S&p Scp Etf (IJR)
Adobe Systems Incorporated (ADBE)

View all positions for A. Montag and Associates

Top funds holding Affimed Therapeutics B V

Ridgeback Capital Investments
683 Capital Management
NEA Management Company
Point72 Asset Management
Millennium Management
Vanguard Group
Two Sigma Advisers
Kennedy Capital Management
Two Sigma Investments
Marshall Wace
Alyeska Investment Group
Standard Life Aberdeen
Ewa
Wells Fargo & Company
Two Sigma Securities

View all funds holding Affimed Therapeutics B V